Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-082302
Filing Date
2016-02-16
Accepted
2016-02-16 13:09:06
Documents
51
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v431178_10q.htm 10-Q 459541
2 EXHIBIT 31.1 v431178_ex31-1.htm EX-31.1 10625
3 EXHIBIT 32.1 v431178_ex32-1.htm EX-32.1 4450
  Complete submission text file 0001144204-16-082302.txt   4708019

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ppch-20151231.xml EX-101.INS 820056
5 XBRL TAXONOMY EXTENSION SCHEMA ppch-20151231.xsd EX-101.SCH 54579
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppch-20151231_cal.xml EX-101.CAL 35413
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ppch-20151231_def.xml EX-101.DEF 304178
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppch-20151231_lab.xml EX-101.LAB 315574
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppch-20151231_pre.xml EX-101.PRE 333095
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 161425797
SIC: 2834 Pharmaceutical Preparations